3 results
Approved WMOCompleted
1. Overall survival (primary efficacy endpoint)2a. Efficacy: progression-free survival (PFS), overall response rate (ORR = CR + PR), and a clincal benefit rate (CBR) will be evaluated as CR + PR + SD for at least 3 months.2b. Safety: adverse events…
Approved WMORecruiting
• To assess the tolerability and safety of the investigational medicinal product
Approved WMOCompleted
To assess the effect of prehospital administration of crushed tablets of prasugrel loading dose (in addition to ASA and standard care) on safety and efficacy in patients treated with primary PCI for acute STEMI with last-generation DES (Firehawk*,…